Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Kura Oncology
Over the past year MLTX returned +83.3% and KURA returned +20.5%; their daily moves had a correlation of 0.24.
MLTX +83.3% KURA +20.5%Growth of $1, one year, split-adjusted
| Metric | MLTX | KURA |
|---|---|---|
| Price | $11.45 | $10.81 |
| Market cap | $974.5M | $961.2M |
| Today | −0.95% | +1.84% |
| 1 month | −23.6% | −14.7% |
| 6 months | −32.4% | +39.8% |
| Year to date | −13.1% | +4.0% |
| 1 year | −81.5% | +19.4% |
| Revenue growth (YoY) | — | +36.5% |
| Gross margin | — | 98.8% |
| Net margin | — | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 12.4× |
| Net cash | $437.5M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 52.2% | 58.5% |
| Short % of float | 14.6% | 19.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).